Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Pharmacotherapy|March 11, 2000
Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonistsJ C Song, C M WhiteThe Annals of Pharmacotherapy|February 24, 2001
Do HMG-CoA reductase inhibitors affect fibrinogen?J C Song, C M WhitePharmacotherapy|April 20, 2001
Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteersR Ammar, J C Song, J Kluger, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 2, 2001
Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspensionJ C Song, R A Quercia, C Fan, et al.Pharmacotherapy|June 10, 1998
Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitorsC M WhiteThe Annals of Pharmacotherapy|October 26, 1999
Prevention of suboptimal beta-blocker treatment in patients with myocardial infarctionC M WhiteJournal of Clinical Pharmacology|May 11, 1999
A review of potential cardiovascular uses of intravenous glucagon administrationC M WhiteJournal of Clinical Pharmacology|September 21, 2001
Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulationC M WhiteAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 29, 1998
Catecholamines and their blockade in congestive heart failureC M WhiteAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2000
Angiotensin-converting-enzyme inhibition in heart failure or after myocardial infarctionC M WhitePageof 16